Fighting Drug-Resistant Malaria with Counterfeit, Falsified, and Substandard Drugs: A Sure Recipe for Disaster

Summary: CSIS Global Health Policy Center Senior Associate J. Christopher Daniel discusses the duel threats presented by drug-resistant malaria and treatment of the disease with substandard or counterfeit drugs.